🐋 CRWV $14.3M Dual-Leg Options Tape — Whale Sells Covered $120 Calls, Books Near-Dated $115 Calls After Meta + Anthropic Deals

📅 April 16, 2026 | 🔥 Unusual Options Activity Detected

---

🎯 The Quick Take

At 12:07:55 today, the same institutional player simultaneously sold 22,000 May 8 $120 calls for $9.4M and bought 24,000 April 17 $115 calls for $4.9M — a $14.3M two-legged structure printed at identical timestamps with spot CRWV at $118.66. This isn't two separate bets: the buy-write / calendar structure telegraphs a trader who owns a large CRWV stock position and is monetizing the top of the post-deal spike while keeping short-dated upside exposure into tomorrow's expiration. With CoreWeave up more than 50% in April alone on the Meta $21B deal, Anthropic partnership, and Jane Street's $1B equity investment, today's tape reads like smart money taking partial profit on the rally while leaving a foot in the door for more upside.

---

📊 Company Overview

CoreWeave (NASDAQ: CRWV) is the leading independent GPU cloud provider, purpose-built for AI and high-performance computing workloads. Unlike traditional cloud hyperscalers, CoreWeave operates NVIDIA-exclusive infrastructure — first with B200/GB200 clusters at scale, and now securing access to NVIDIA Vera Rubin systems. Nine of the ten largest AI model companies run on CoreWeave.

• Market Cap: ~$62.4 billion (Yahoo Finance)
• Industry: AI Infrastructure / Hyperscaler GPU Cloud
• Current Price: $118.66 (intraday at time of trade); $117.81 close
• 52-Week Range: $33.52 – $187.00
• IPO: March 2025 at $40/share — stock is up ~195% from IPO in 13 months
• Revenue Backlog: $66.8B as of December 31, 2025 (growing fast with April deal additions)
• FY2026 Guidance: $12–13B revenue (~140% YoY growth at midpoint)

---

💰 The Option Flow Breakdown

The Tape (April 16, 2026 @ 12:07:55 — both legs printed simultaneously):

Net premium collected: ~$4.5M (sold $9.4M, bought $4.9M)

🤓 What This Actually Means

Let's break down what just happened with these two simultaneous legs:

Leg 1 — Sell $120 Calls, May 8 expiration ($9.4M):

• 💸 Sold 22,000 contracts for $9.53 each against only 185 contracts of open interest — that's massive new short call exposure
• 🛡️ At spot $118.66, the $120 strike is just 1.1% out of the money, expiring in 22 days
• 📊 The open/close classifier flags this as STO (Sell-to-Open) — new position, not a close
• 🎯 This looks like a covered call written against a large existing long stock position — collecting $9.53/share in premium to cap upside at $120 through May 8

Leg 2 — Buy $115 Calls, April 17 expiration ($4.9M):

• 📈 Bought 24,000 contracts at $4.98 each — these expire TOMORROW
• 🔥 The $115 strike is already $3.66 in-the-money with spot at $118.66, so this is deep ITM
• 📊 Classified as BTC (Buy-to-Close) with Z-score of 7.86 (EXTREMELY UNUSUAL — happens only a few times a year in CRWV)
• 🎯 Buying back near-expiry ITM calls suggests they previously sold these $115 calls and are closing a short call position before tomorrow's expiration

The Combined Picture: This is a covered call roll — the trader is closing out a short $115 call that expires tomorrow (paying $4.9M to close), and simultaneously writing a new short $120 call at a further-out May 8 expiration (collecting $9.4M). The net effect: they're rolling up $5 in strike price and out 22 days in time, all while pocketing ~$4.5M net premium. This is classic institutional stock-plus-short-call management — not a directional bet, but disciplined income extraction on a position that has moved their way.

The $115 buy-to-close being tagged as EXTREMELY UNUSUAL (7.86 Z-score) confirms the size is way outside normal CRWV options activity — this is large institutional hands, not retail.

---

📈 Technical Setup / Chart Check-Up

YTD Performance

CRWV has been an absolute story stock in 2026. Starting the year around $70-75, shares collapsed to the low-$60s in February-March after Q4 2025 earnings (Feb 26) missed EPS and shocked with $8.2B quarterly capex. Then the April deal cluster hit: Meta $21B (April 9), Anthropic (April 10), Jane Street $6B + $1B equity (April 15). The stock screamed from below $80 to a high of $187 before pulling back to current levels around $117-118.

Key observations:

• 📈 CRWV is up >60% YTD and ~195% from its IPO price of $40
• 🎢 Max drawdown of ~60% from 52-week high of $187 to current $117 shows extreme volatility
• 📊 The April rally was near-vertical — 50%+ in two weeks, driven purely by deal announcements
• ⚠️ Stock gave back roughly $30-40 from intraday highs as the initial euphoria settled
• 🔴 Insider selling pressure is real — 1.1M CRWV shares sold April 14-15 (Markets Daily)

🔵🟠 Gamma-Based Support and Resistance Analysis

Current Price: $116.96 (at GEX snapshot time)

The gamma exposure map reveals where market makers are concentrated and where price will find the most friction:

🔵 Support Levels (Put Gamma Below Price):

• $116 — Nearest support, 2.87B total GEX, with slight put-heavy net bias (-1.07B net) — immediate floor just below current price
• $115 — Strong support at 24.0B total GEX (dominated by 22.1B call gamma — likely where the $115 strike from this trade has heavy OI concentration). This is the critical near-term floor — and exactly where today's BTC leg was struck
• $110 — Secondary support at 22.7B total GEX; ~6% below current price
• $105 — Extended support zone at 8.4B GEX; ~10% below current
• $100 — Deep support at 9.3B GEX; psychological round number ~14.5% below

🟠 Resistance Levels (Call Gamma Above Price):

• $117 — Immediate overhead resistance at 4.1B GEX; barely above current price — market makers cap rallies here in the short term
• $120 — Key resistance at 13.6B total GEX, heavily call-dominated (11.5B call GEX vs 2.1B put GEX). This is EXACTLY where today's sold calls are struck — the trader is capping their position at the strongest nearby resistance. Smart placement.
• $125 — Secondary resistance at 5.3B GEX; 6.9% above current
• $130 — Meaningful ceiling at 11.1B GEX; ~11% above current — would require sustained buying to break
• $140 — Extended resistance at 2.6B GEX; ~20% above current

What This Means for CRWV Traders: The GEX summary shows a bullish net bias overall (128.6B total call GEX vs 36.0B put GEX), but the pinning action around $115-120 is real. The trader who sold the $120 calls is essentially anchoring their covered call at the single strongest overhead resistance — they're getting paid to sell at exactly the level where market maker positioning will create natural selling pressure. That's not luck; that's experience.

Net GEX Bias: Bullish (128.6B call GEX vs 36.0B put GEX) — overall positioning supports higher prices, but near-term capped by $120 wall.

📅 Implied Move Analysis

Options market pricing for upcoming expirations (from $117.18 reference price):

• 📅 Tomorrow (April 17 — 1 day, THIS IS WHEN LEG 2 EXPIRES): ±$4.11 (±3.5%) → Range: $113.07 – $121.29
• 📅 May 15 OPEX (29 days): ±$9.39 → Range: $107.79 – $126.57
• 📅 June 19 Triple Witch (63 days): ±$14.84 → Range: $102.34 – $132.02
• 📅 July 17 OPEX (91 days): ±$20.28 → Range: $96.90 – $137.46
• 📅 LEAP March 2027 (337 days): ±$59.56 (±50.8%) → Range: $57.62 – $176.74

Key Insights: The ±3.5% daily move ($4.11) for tomorrow is notable — with Q1 earnings coming May 20, and the stock riding massive deal announcements, 3.5% intraday swings are expected as baseline. The $115 calls expiring tomorrow were deep in the money ($3.66 ITM) when bought-to-close, so the BTC leg was about certainty of closing, not speculation.

The May 15 implied range ($107.79–$126.57) overlaps nearly perfectly with the new short $120 calls (May 8 expiry) — the market is telling you the upper bound through May is right where this trader sold. The $130 level doesn't become part of the implied move range until the June Triple Witch expiration.

Q1 Earnings Implied Move (May 20): Earnings fall between the May 15 and June 19 expirations. Based on the implied move progression, expect a 10–15% earnings move priced in by late April/early May for the May 20 event — either direction. The $120 short call (expiring May 8) will be off the books before earnings, giving the trader clean long exposure into the Q1 print.

---

🎪 Catalyst Context

🔥 Recent Catalysts That Drove the April Rally

Meta $21B AI Cloud Expansion — April 9, 2026: CNBC reported CoreWeave signed a multi-year agreement to provide AI cloud capacity to Meta through December 2032, valued at approximately $21 billion. Combined with the prior $14.2B contract, total Meta commitment now stands at ~$35.2B — making Meta CoreWeave's single largest customer. Bloomberg noted deployments will use NVIDIA Rubin systems. A separate $3 billion convertible notes issuance was announced alongside the deal to fund continued capex.

Anthropic Multi-Year Deal — April 10, 2026: CNBC reported CoreWeave and Anthropic signed a multi-year agreement to power development and deployment of the Claude model family at production scale. Financial terms were not disclosed. Bloomberg confirmed first compute comes online in H2 2026 in a phased rollout. With Anthropic added, 9 of the 10 largest AI model providers now run on CoreWeave. Note: this platform does not power Claude via CoreWeave yet; that begins later in 2026.

Jane Street $6B Cloud Deal + $1B Equity Investment — April 15, 2026: Bloomberg reported Jane Street committed $6 billion to use CoreWeave's AI cloud platform (including access to NVIDIA Vera Rubin systems) AND made a $1 billion equity investment at $109/share — a 176% premium to the March 2025 IPO price. Jane Street is now a top-5 shareholder. The CoreWeave announcement confirmed this is one of the largest single-entity AI infrastructure commitments from a financial firm.

⚠️ Overhang: Insider Selling

Markets Daily reported that an insider sold 1,125,000 shares on April 14-15 alongside a COO sale of 7,335 shares. Since the IPO lockup expired in August 2025, insiders including CEO Michael Intrator and Magnetar have sold over $1B in shares — the same week the stock was hitting highs on the deal news. Hard to ignore when the people who built the company are aggressively monetizing.

📅 Upcoming Catalyst: Q1 2026 Earnings — May 20, 2026

Per MarketBeat, CoreWeave reports Q1 2026 results on May 20, 2026 after close — 34 days away. This is the next binary event.

Key metrics the Street will focus on:

• Revenue: Consensus $1.9–2.0B (company guidance midpoint ~$1.95B; must hit or exceed to maintain credibility)
• EPS: Analyst consensus ~-$0.91; company guides Q1 adj. operating income $0–40M (first path toward profitability)
• Capex: $6–7B Q1 capex guided — Street will scrutinize whether the $2.60 capex-per-$1-revenue ratio is improving
• Interest Expense: Guided at $510–590M for Q1 — tripled YoY, the central bear thesis pressure point
• Backlog: Was $66.8B at year-end; with Meta $21B + Jane Street $6B added in April, backlog should be approaching $90B+ and any reduction would be alarming
• Customer concentration: Microsoft was 62% of 2024 revenue; watch for continued diversification toward Meta and OpenAI

The May 8 short $120 calls (from today's trade) expire 12 days before earnings — the trader will have clean uncapped exposure into the Q1 print. That timing is deliberate.

---

🎲 Price Targets and Probabilities

Using gamma levels, implied move ranges, and catalyst timing:

📈 Bull Case — 35% Probability

Target: $130–$140 through June Triple Witch

How we get there:

• ✅ Q1 2026 earnings on May 20 deliver $2.0B+ revenue (beating the $1.95B midpoint), with a path to adjusted operating income positive
• 🚀 Backlog disclosure confirms $90B+ (Meta $21B + Jane Street $6B additions fully reflected)
• 🤖 Anthropic capacity comes online ahead of schedule, adding to revenue credibility
• 📊 Microsoft concentration continues declining below 30%, reducing single-customer risk optics
• 🔨 Break above $120 gamma resistance triggers gamma-fueled squeeze toward $125–$130 (June implied upper range: $132.02)
• 💪 Additional hyperscaler or enterprise customer announcement in May

P&L on the short $120 calls (May 8) in this scenario: Short $120 calls go in the money — the trader gets called away on their stock at $120, realizing the $9.53 premium collected as income but capping stock gains above $120 through May 8. Net outcome is still profitable for the overall position, just capped.

🎯 Base Case — 45% Probability

Target: $110–$120 range (consolidation)

Most likely scenario:

• ⚖️ Stock digests the 50% April rally; short-term consolidation between $115 gamma support and $120 GEX resistance
• 📊 Short $120 calls expire worthless May 8 (stock stays below $120) — trader keeps full $9.4M premium
• 🔄 Q1 earnings on May 20 in-line with guidance — $1.9–2.0B revenue, adj. operating income near breakeven
• 📉 Insider selling continues to create supply overhang
• 💤 Volatility normalizes between deal announcements; CRWV trades in $110–$125 band into earnings
• 🎯 The $115 gamma wall (24.0B GEX) acts as the floor; the $120 GEX wall (13.6B) caps the top

This is the best outcome for the covered call seller — full premium captured, stock stays in range.

📉 Bear Case — 20% Probability

Target: $100–$110 (test of deeper support)

What could go wrong:

• 😰 Pre-earnings jitters as traders focus on the $510–590M Q1 interest expense — $2B in quarterly revenue barely covers the interest bill alone
• 🚨 Additional 1M+ share insider sales accelerate ahead of May 20 earnings
• ⚖️ Broader tech/AI selloff on macro data (tariff escalation, rate policy) hits high-beta CRWV hardest
• 📊 Break below $116 immediate support → flush toward $115 (still strong GEX wall) → if $115 fails, $110 is next at 22.7B GEX
• 🐻 Bernstein underperform thesis gains traction — Bernstein argues hyperscalers will insource at renewal; Barclays has a $90 PT
• 💸 Texas Project Horizon termination already showed GW-scale capacity builds can collapse — any similar capacity miss would be severe

Critical bear levels:

• 🛡️ $115: Strong GEX floor (24.0B total GEX) — must hold or momentum turns
• 🛡️ $110: Secondary support (22.7B GEX), ~6% downside from here
• 🛡️ $100: Psychological round-number floor at 9.3B GEX; ~14.5% below current

---

💡 Trading Ideas

🛡️ Conservative: Sell the Covered Call — Copy the Whale

Play: If you own CRWV stock, write the May 8 $120 call (mimicking today's institutional trade)

Why this works:

• 🎯 Collect roughly $9–10 in premium (~8% of stock price) for capping upside at $120 through May 8
• ⏰ Expires 12 days before Q1 earnings on May 20 — you get clean unhedged exposure into the earnings print
• 📊 Selling exactly at the $120 GEX resistance wall means market maker positioning is working FOR you, not against you
• 💰 In base case (stock stays below $120 through May 8), you keep the full premium with zero exercise
• 🛡️ Provides ~8% cushion if stock dips from current levels

Estimated outcome:

• Collect ~$9.50/share premium (per 100 shares = $950 per contract)
• If stock below $120 on May 8: keep $9.50 premium in full, still own stock
• If stock above $120 on May 8: shares called away at $120 + $9.50 = effective $129.50 exit — still solid

Risk level: Low-moderate (defined by stock ownership + premium collected) | Skill level: Intermediate

⚖️ Balanced: May $115/$125 Bull Call Spread (Earnings Setup)

Play: Buy May 15 $115 call, sell May 15 $125 call (before May 20 earnings)

Why this works:

• 🎰 Risk-defined way to express a bullish view into Q1 earnings without naked long call exposure
• 📊 Targets the $125 GEX resistance (5.3B GEX) as the upside ceiling — aligns with May 15 implied upper range of $126.57
• 💰 Estimated net debit: $6–8 per spread (depends on IV)
• 🎯 Breakeven around $121–123; max profit if stock above $125 at May 15 expiry = $10 minus debit paid
• ⏰ You want to close or roll this before May 20 earnings to avoid binary earnings risk in the position

Position sizing: Risk 2–3% of portfolio maximum; this is speculative given CRWV's volatility

Risk level: Moderate | Skill level: Intermediate

🚀 Aggressive: Near-Term Straddle for Earnings Volatility (Advanced Only)

Play: Buy May 20 $115 straddle (at-the-money call + put) — capturing earnings binary

Why this could work:

• 💥 CRWV has moved 20–30% on prior earnings prints; the options market may underprice actual realized move
• 📈 Bull scenario: revenue beat + positive backlog = $130+ (13% upside)
• 📉 Bear scenario: EPS miss + capex shock (happened Feb 26) = $95–105 territory
• 🎢 High IV stock means elevated straddle cost — only profitable if move exceeds ~13–15%

Why this could blow up (serious risks):

• 💸 Straddle on CRWV with 50%+ IV will cost $20–25 per share — time decay brutal
• 😱 IV crush post-earnings will compress both legs even if stock moves 8–10%
• ⚠️ Stock could stay rangebound $110–$125 into earnings — 100% premium loss
• ❌ Do NOT attempt without prior straddle experience through earnings

Breakeven (approximate): Stock needs to trade below ~$93 or above ~$137 at expiry to profit after IV crush

Risk level: High (can lose full premium) | Skill level: Advanced only

---

⚠️ Risk Factors

Do not ignore these:

• 💸 Balance sheet is stretched to an extreme: Total liabilities of ~$29B against ~$3.9B of equity, with Q1 2026 interest expense guided at $510–590M. That is nearly $2B of annual interest cost alone — against $1.9–2.0B of Q1 revenue guidance. The entire bull thesis rests on the $66.8B backlog converting to cash faster than the debt compounds. If AI capex slows or a large contract is canceled, the solvency math gets uncomfortable fast.

• 🐻 Bernstein and Barclays are not wrong to be skeptical: Bernstein maintains an underperform, arguing hyperscalers (AWS, Azure, GCP) have deeper balance sheets and will insource at contract renewal. Barclays targets $90 — nearly 25% below current. These are not fringe views; they represent real execution risk on multi-year contracts.

• 👤 Insider selling is persistent and large: The same week three transformational deals were announced, an insider sold 1.1M shares — adding to more than $1B sold since the August 2025 lockup expiry. When the people building the company keep selling aggressively into every rally, it is worth pausing.

• ⚡ Extreme realized volatility: CRWV traded from the low $60s to a $187 high and back to $117 within roughly three months. That is an 83% peak-to-trough swing from the February lows to April highs, followed by a ~37% correction from the intraday high. This is not a stock where you can afford to be wrong on size or leverage.

• 🏗️ Capex and power execution risk: The Texas Project Horizon termination (2GW data center deal collapsed) shows gigawatt-scale builds are fragile. Pennsylvania state legislators are actively debating data center power and water frameworks that could affect CoreWeave's Lancaster $6B build. Construction delays could trigger contract penalties or backlog slippage.

• 📊 Customer concentration remains high: Even after the April diversification, Meta + OpenAI + Microsoft still dominate the backlog. A decision by any one of those three to slow spending would materially impact the revenue trajectory. The Sherwood News analysis frames this risk clearly — CoreWeave is simultaneously the beneficiary and hostage of hyperscaler AI spending cycles.

• ⏰ May 20 earnings is a binary event: With the stock up 60%+ YTD, expectations are elevated. The Q4 2025 print on February 26 already demonstrated how quickly CRWV can reprice down — shares fell ~8% despite a revenue beat because the capex surprise ($8.2B vs $6B estimate) spooked the market. If Q1 follows the same pattern (revenue in-line, capex shock), the reaction could be sharper given the larger recent rally.

---

🎯 The Bottom Line

Real talk: Today's $14.3M dual-leg print is not a directional bet — it is a sophisticated covered call roll executed by an institution that owns a large CRWV stock position and is actively managing it. They bought back a short $115 call expiring tomorrow (probably written when the stock was lower), and immediately rolled it up to a short $120 call expiring May 8. Net result: they collected ~$4.5M in net premium, extended their covered call another 22 days, and raised their cap from $115 to $120. If CRWV stays below $120 through May 8, they pocket the full $9.4M sell leg and own their stock clean into Q1 earnings on May 20.

What this trade tells us:

• 🎯 The institutional holder believes $120 is a ceiling — at least through May 8. They are willing to cap their upside there in exchange for $9.53/share in immediate income
• ⚖️ They are not bearish — they are staying long the stock, just extracting premium at resistance
• 📊 The $115 GEX wall (24.0B total GEX) and the $120 resistance (13.6B GEX) perfectly frame the range where this position is being managed
• ⏰ The May 8 expiry choice is deliberate — it cleans up covered call exposure before May 20 Q1 earnings, leaving the trader free to participate in the earnings move uncapped

If you own CRWV:

• ✅ Consider writing covered calls at $120 (May 8 or May 15) — collect 8–9% premium while waiting for May 20 earnings
• 📊 Set a mental stop at $115 (first strong GEX floor) — if that breaks, reassess position size
• 👀 Watch Q1 earnings (May 20) closely: the $1.9–2.0B revenue target is achievable, but interest expense ($510–590M) and capex ($6–7B for Q1 alone) will dominate the narrative
• ⚠️ Insider selling has been aggressive into every rally — size your position accordingly

If you are watching from the sidelines:

• 📅 May 20, 2026 after close is the moment of truth — Q1 2026 earnings
• 🎯 A pullback to $110–$115 gamma support would be a better entry than chasing at current levels after a 50% April sprint
• 📈 Bull thesis requires: backlog growing past $75–80B, revenue on track to $12B+ FY2026, and some improvement in interest coverage ratio
• ⚠️ Current valuation at roughly 12x 2026E revenue leaves limited margin for execution error

Mark your calendar:

• 📅 April 17 (tomorrow) — $115 calls (bought-to-close today) expire; implied move ±$4.11 from $117.18
• 📅 May 8 — Short $120 calls (sold today) expire; 12 days before earnings
• 📅 May 15 — Monthly OPEX; implied range $107.79–$126.57
• 📅 May 20 — Q1 2026 earnings after close; THE binary event for 2026 H1
• 📅 H2 2026 — Anthropic phased capacity begins coming online per April 10 announcement

Final verdict: CoreWeave has the most impressive contract backlog story in public tech — $66.8B going to $90B+ with April additions, 9 of 10 largest AI labs as customers, and NVIDIA next-gen hardware priority. But the debt load ($29B liabilities vs $3.9B equity), the $510–590M quarterly interest expense guided for Q1, and relentless insider selling are not details you can wish away at a $62B market cap. Today's institutional tape is the smart-money answer: stay long, sell calls at resistance, collect income, and let May 20 earnings be the next decision point.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and not financial advice. Past performance does not guarantee future results. The unusual options activity described reflects a single day's tape and does not imply the trade will be profitable or that following it is appropriate for any specific investor's situation. CRWV is a high-volatility stock with extreme intraday ranges — position sizing discipline is essential. Always do your own research and consider consulting a licensed financial advisor before trading.

---

About CoreWeave (NASDAQ: CRWV): CoreWeave is the leading GPU-native AI cloud provider, operating NVIDIA-exclusive infrastructure at hyperscale. The company serves 9 of the 10 largest AI model developers — including Meta, OpenAI, Microsoft, Anthropic, Google, IBM, Mistral, and Cohere — with a $66.8B revenue backlog as of December 31, 2025 and FY2026 revenue guidance of $12–13B. Market cap approximately $62.4 billion.